MISSENSE POLYMORPHISM (C T224) IN THE HUMAN CATHEPSIN-D PRO-FRAGMENT DETERMINED BY POLYMERASE CHAIN-REACTION - SINGLE-STRAND CONFORMATIONALPOLYMORPHISM ANALYSIS AND POSSIBLE CONSEQUENCES IN CANCER-CELLS/

Citation
I. Touitou et al., MISSENSE POLYMORPHISM (C T224) IN THE HUMAN CATHEPSIN-D PRO-FRAGMENT DETERMINED BY POLYMERASE CHAIN-REACTION - SINGLE-STRAND CONFORMATIONALPOLYMORPHISM ANALYSIS AND POSSIBLE CONSEQUENCES IN CANCER-CELLS/, European journal of cancer, 30A(3), 1994, pp. 390-394
Citations number
31
Categorie Soggetti
Oncology
Journal title
ISSN journal
09598049
Volume
30A
Issue
3
Year of publication
1994
Pages
390 - 394
Database
ISI
SICI code
0959-8049(1994)30A:3<390:MP(TIT>2.0.ZU;2-P
Abstract
Overexpression of cathepsin D in human breast cancers is associated wi th a higher risk of relapse and metastasis. Also, pro-enzyme routing i s altered in several tumoral mammary cell lines, leading to its hypers ecretion. MCF7 cells compared to normal kidney carry a C --> T transit ion at position 224 in the cathepsin D gene which converts Ala to vali ne in its pro-fragment. Using polymerase chain reaction-single strand conformational polymorphism analysis (PCR-SSCP), the variant T allele frequency was found to be 23-30%, and equally distributed in cancer an d normal cells. Six to nine per cent of genotypes were homozygous T/T, 34-41% were heterozygous T/C and 50-59% were homozygous C/C. Moreover , genotypes were identical in 19 out of 20 matched sets of tumoral mam mary cells and normal white blood cells from the same patients. Loss o f heterozygosity was noted in 1 case. C/T224 transition is thus not du e to a somatic event. However, this missense polymorphism might modify procathepsin D secretion and/or maturation in breast cancer cells.